Skuteczność działania pradofloksacyny w leczeniu ropnych zapaleń skóry u psów – opis przypadku

Piśmiennictwo

Beck K.M., Waisglass S.E., Dick H.L.N.: Prevalence of meticillin-resistant Staphylococcus pseudintermedius (MRSP) from skin and carriage sites of dogs after treatment of their meticillin-resistant or meticillin-sensitive staphylococcal pyoderma. „Vet Dermatol”, 2012; 23: 369-e67.Summers J.F., Brodbelt D.C., Forsythe P.J.: The effectiveness of systemic antimicrobial treatment in canine superficial and deep pyoderma: a systematic review. „Vet Dermatol”, 2012; 23: 305-61.Mueller R.S., Bernd S.: Pradofloxacin in the treatment of canine deep pyoderma: a multicentred, blinded, randomized parallel trial. First International Veraflox® Symposium, Berlin, 16-19 March 2006.Scott D.W., Miller W.H. Jr, Griffin C.E.: Muller and Kirk’s Small Animal Dermatology. W.B. Saunders, Philadelphia 2001.DeBoer D.J.: Strategies for management of recurrent pyoderma in dogs. „Veterinary Clinics of North America Small Animal Practice”, 1990; 20: 1509-24.Pridmore A., Stephan B., Greife H.A.: In vitro activity of pradofloxacin against clinical isolates from European field studies. Proceedings of the 105th General Meeting of the American Society for Microbiology, 2005.Stephan B., Pridmore A., Silley P.: In vitro activity of pradofloxacin and metronidazole against anaerobic bacteria from dogs and cats. Proceedings of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, 2003.Abraham J., Ewert K., de Jong A.: Pradofloxacin: comparative in vitro activity against selected pathogens from the US. Proceedings of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, 2002.

dr n. wet. Kourou DembeleKatedra Chorób Małych Zwierząt z KlinikąWydział Medycyny WeterynaryjnejSGGW w Warszawie02-776 Warszawa ul. Nowoursynowska 159